Dr. Ndzengue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
877 Jefferson Ave
Memphis, TN 38103Phone+1 901-545-7100Fax+1 901-302-2360
Education & Training
One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 2009 - 2012
University of Yaounde IClass of 1998
Certifications & Licensure
MS State Medical License 2016 - 2025
TN State Medical License 2015 - 2025
AL State Medical License 2020 - 2024
FL State Medical License 2021 - 2024
TX State Medical License 2020 - 2024
IA State Medical License 2020 - 2023
SC State Medical License 2016 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsNon-islet cell tumor hypoglycemia associated with uterine leiomyomata.Albert Ndzengue, Zwege Deribe, Richard B. Rafal, Maximo Mora, Schiller Desgrottes
Endocrine Practice. 2011-07-01 - 75 citationsA new clinically based staging system for perihilar cholangiocarcinoma.Roongruedee Chaiteerakij, William S. Harmsen, Carlos Romero Marrero, Mohammed M. Aboelsoud, Albert Ndzengue
The American Journal of Gastroenterology. 2014-11-11 - 39 citationsAntitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cellsXiwei Ding, Roongruedee Chaiteerakij, Catherine D. Moser, Hassan M. Shaleh, Jeffrey Boakye
Oncotarget. 2016-03-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
